期刊文献+

诊断黑色素瘤的放射性药物研究进展

Research Progress of Melanoma Imaging with Radionuclide Agents
下载PDF
导出
摘要 相比CT、超声、MRI等影像手段,核医学放射性核素显像特异性较高,随着更多新型显像剂的研究,可在分子水平了解病灶、受体的结构功能以及代谢情况,能够更早发现黑色素瘤的原发灶与转移灶。本文从单光子和正电子类显像剂角度综述了近年核医学放射性药物诊断黑色素瘤的研究进展。 In comparison with CT,ultrasonography,MRI et al,scintigraphic imaging have the advantages of high specificity and recognizes lesions and structure-function of the receptor and metabolism in molecular level,which could diagnose melanoma and its metastasis earlier.With the emergence of more new imaging agents,this unique advantage was more obviously.This article discussed the latest research progress of melanoma imaging with radionuclide agents from aspects of single photon and positron.
出处 《同位素》 CAS 2015年第4期238-247,共10页 Journal of Isotopes
基金 泸州市科技局项目(14JC01393-LH47) 四川医科大学科研项目(2012ZD-05)
关键词 黑色素瘤 单光子 正电子 显像剂 melanoma single photon positron imaging
  • 相关文献

参考文献55

  • 1Rigel D S, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs[J]. CA-A Cancer Journal for Clinicians, 2010, 60(5): 301-316.
  • 2Jemal A, Siegel R, Xu J, et al. Cancer statistics[J]. 2010. CA-A Cancer Journal for Clinicians, 2010, 60(5): 277-300.
  • 3Garbe C, Eigentler T K. Diagnosis and treatment of cutaneous melanoma: state of the art 2006[J]. Melanoma Research, 2007, 17(2): 117-127.
  • 4Jennings L, Murphy G M. Predicting outcome in melanoma: where are we now?[J]. British Journal of Dermatology, 2009, 161(3): 496-503.
  • 5Balch C M, Soong S J, Gershenwald J E, et al. Prognostic factors analysis of 17 600 melanoma patients: validation ofthe American Joint Committee on Cancer melanoma staging system[J]. Journal of Clinical Oncology, 2001, 19(16): 3622-3634.
  • 6Miller A J, Mihm MC J r. Melanoma[J]. New England Journal of Medicine, 2006, 355(1): 51-65.
  • 7Massoud TF, Gambhir SS. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light[J]. Genes & Development, 2003, 17(5): 545-580.
  • 8Cheng Z, Chen J Q , Miao Y B, et al. Modification of the structure of a metallopeptide: Synthesis and biological evaluation of111In-labeled DOTA-conjugated rhenium-cyclized α-MSH analogues[J]. Journal of Medicinal Chemistry, 2002, 45(14): 3048-3056.
  • 9Miao Y B, Gallazzi F, Guo H X, et al.111In-labeled lactam bridge-cyclized α-melanocyte stimulating hormone peptide analogues for melanoma imaging[J]. Bioconjugate Chemistry, 2008, 19(2): 539-547.
  • 10Guo H X, Yang J Q, Gallazzi F, et al. Effect of DOTA position on melanoma targeting and pharmacokinetic properties of111In-labeled lactam bridge-cyclized α-melanocyte stimulating hormone peptide[J]. Bioconjugate Chemistry, 2009, 20(11): 2162-2168.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部